nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—PTGS2—melanoma	0.447	0.529	CbGaD
Piroxicam—ALB—melanoma	0.398	0.471	CbGaD
Piroxicam—ALB—Vemurafenib—melanoma	0.0553	1	CbGbCtD
Piroxicam—SLC22A8—optic choroid—melanoma	0.00308	0.222	CbGeAlD
Piroxicam—Lornoxicam—PTGS2—melanoma	0.00178	0.354	CrCbGaD
Piroxicam—Tenoxicam—PTGS2—melanoma	0.00158	0.315	CrCbGaD
Piroxicam—PTGS2—leg—melanoma	0.00155	0.112	CbGeAlD
Piroxicam—PTGS2—hindlimb—melanoma	0.00138	0.0999	CbGeAlD
Piroxicam—PTGS2—appendage—melanoma	0.00119	0.0857	CbGeAlD
Piroxicam—Meloxicam—PTGS2—melanoma	0.00113	0.225	CrCbGaD
Piroxicam—PTGS2—skin epidermis—melanoma	0.000988	0.0713	CbGeAlD
Piroxicam—PTGS1—endothelium—melanoma	0.00075	0.0541	CbGeAlD
Piroxicam—PTGS2—endothelium—melanoma	0.000717	0.0517	CbGeAlD
Piroxicam—PTGS1—blood vessel—melanoma	0.000692	0.0499	CbGeAlD
Piroxicam—PTGS2—blood vessel—melanoma	0.000661	0.0477	CbGeAlD
Piroxicam—SLC22A8—eye—melanoma	0.00062	0.0448	CbGeAlD
Piroxicam—Oxcarbazepine—ALB—melanoma	0.000536	0.107	CrCbGaD
Piroxicam—SLC22A8—head—melanoma	0.000352	0.0254	CbGeAlD
Piroxicam—PTGS1—skin of body—melanoma	0.00032	0.0231	CbGeAlD
Piroxicam—PTGS2—skin of body—melanoma	0.000306	0.0221	CbGeAlD
Piroxicam—PTGS1—mammalian vulva—melanoma	0.000292	0.0211	CbGeAlD
Piroxicam—ALB—lymph node—melanoma	0.000257	0.0185	CbGeAlD
Piroxicam—PTGS1—head—melanoma	0.000209	0.0151	CbGeAlD
Piroxicam—PTGS2—head—melanoma	0.0002	0.0144	CbGeAlD
Piroxicam—PTGS1—lymph node—melanoma	0.000146	0.0106	CbGeAlD
Piroxicam—PTGS2—lymph node—melanoma	0.00014	0.0101	CbGeAlD
Piroxicam—CYP2C9—Metabolism—PLCB4—melanoma	3.07e-05	0.000383	CbGpPWpGaD
Piroxicam—ALB—Metabolism—LUM—melanoma	3.05e-05	0.000381	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PHGDH—melanoma	3.05e-05	0.000381	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.02e-05	0.000377	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—HPSE—melanoma	3.01e-05	0.000376	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.01e-05	0.000376	CbGpPWpGaD
Piroxicam—ALB—Metabolism—HPSE—melanoma	3e-05	0.000374	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.99e-05	0.000374	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.99e-05	0.000373	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.98e-05	0.000372	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CUBN—melanoma	2.96e-05	0.000369	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—HGF—melanoma	2.94e-05	0.000367	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CUBN—melanoma	2.94e-05	0.000367	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CSF2—melanoma	2.91e-05	0.000363	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PLA2G6—melanoma	2.89e-05	0.000361	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIP4K2A—melanoma	2.88e-05	0.00036	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SLC6A11—melanoma	2.88e-05	0.00036	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SDHD—melanoma	2.86e-05	0.000357	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—BSG—melanoma	2.86e-05	0.000357	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CSPG4—melanoma	2.86e-05	0.000357	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SDHD—melanoma	2.84e-05	0.000355	CbGpPWpGaD
Piroxicam—ALB—Metabolism—BSG—melanoma	2.84e-05	0.000355	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CSPG4—melanoma	2.84e-05	0.000355	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—MTAP—melanoma	2.81e-05	0.00035	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PRKCA—melanoma	2.79e-05	0.000348	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—ITGB3—melanoma	2.79e-05	0.000348	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GPAM—melanoma	2.77e-05	0.000345	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP17A1—melanoma	2.76e-05	0.000344	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GPAM—melanoma	2.75e-05	0.000343	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.75e-05	0.000343	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.74e-05	0.000342	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.72e-05	0.00034	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.69e-05	0.000335	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.66e-05	0.000332	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.62e-05	0.000327	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GNA11—melanoma	2.61e-05	0.000325	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—VCAN—melanoma	2.6e-05	0.000324	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAC1—melanoma	2.59e-05	0.000323	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—FASN—melanoma	2.55e-05	0.000318	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.53e-05	0.000316	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—SLC5A5—melanoma	2.51e-05	0.000313	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MMP1—melanoma	2.5e-05	0.000312	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—LUM—melanoma	2.5e-05	0.000312	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PHGDH—melanoma	2.5e-05	0.000312	CbGpPWpGaD
Piroxicam—PTGS2—Disease—GAB2—melanoma	2.47e-05	0.000308	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.46e-05	0.000307	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CDK2—melanoma	2.45e-05	0.000306	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—HPSE—melanoma	2.45e-05	0.000306	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CD44—melanoma	2.42e-05	0.000302	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GNAQ—melanoma	2.42e-05	0.000302	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FASN—melanoma	2.42e-05	0.000302	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CUBN—melanoma	2.41e-05	0.0003	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.4e-05	0.000299	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.37e-05	0.000296	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.37e-05	0.000296	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PLA2G6—melanoma	2.35e-05	0.000294	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.35e-05	0.000293	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PLA2G6—melanoma	2.34e-05	0.000292	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CSPG4—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SDHD—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—BSG—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP1B1—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FOXO4—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CXCR4—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HDAC2—melanoma	2.32e-05	0.00029	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD44—melanoma	2.3e-05	0.000287	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—FN1—melanoma	2.28e-05	0.000285	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.28e-05	0.000285	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—NOS2—melanoma	2.26e-05	0.000282	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GPAM—melanoma	2.25e-05	0.000281	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.25e-05	0.00028	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP17A1—melanoma	2.19e-05	0.000273	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CG—melanoma	2.18e-05	0.000273	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.16e-05	0.00027	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—EGF—melanoma	2.16e-05	0.00027	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.13e-05	0.000266	CbGpPWpGaD
Piroxicam—PTGS2—Disease—AKT3—melanoma	2.12e-05	0.000265	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—VCAN—melanoma	2.11e-05	0.000264	CbGpPWpGaD
Piroxicam—ALB—Metabolism—VCAN—melanoma	2.1e-05	0.000262	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GNA11—melanoma	2.07e-05	0.000258	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.05e-05	0.000256	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—FASN—melanoma	2.02e-05	0.000253	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2e-05	0.00025	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IGF1—melanoma	2e-05	0.00025	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—SLC5A5—melanoma	1.99e-05	0.000249	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.99e-05	0.000248	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.98e-05	0.000247	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.93e-05	0.000241	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CD44—melanoma	1.92e-05	0.00024	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GNAQ—melanoma	1.92e-05	0.00024	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CD—melanoma	1.92e-05	0.00024	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.92e-05	0.00024	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PLA2G6—melanoma	1.91e-05	0.000239	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ABCB1—melanoma	1.91e-05	0.000239	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.88e-05	0.000235	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ERBB4—melanoma	1.87e-05	0.000234	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN2B—melanoma	1.86e-05	0.000232	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP1B1—melanoma	1.84e-05	0.00023	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD86—melanoma	1.79e-05	0.000224	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP17A1—melanoma	1.78e-05	0.000223	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP17A1—melanoma	1.77e-05	0.000221	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PRKCA—melanoma	1.76e-05	0.00022	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.76e-05	0.000219	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.75e-05	0.000218	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ERCC2—melanoma	1.75e-05	0.000218	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FGF1—melanoma	1.74e-05	0.000217	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.74e-05	0.000217	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—VCAN—melanoma	1.72e-05	0.000215	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PDGFRA—melanoma	1.69e-05	0.00021	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GNA11—melanoma	1.68e-05	0.00021	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GNA11—melanoma	1.67e-05	0.000209	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CB—melanoma	1.67e-05	0.000209	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PRKCA—melanoma	1.67e-05	0.000208	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ERCC2—melanoma	1.65e-05	0.000207	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—FASN—melanoma	1.65e-05	0.000206	CbGpPWpGaD
Piroxicam—ALB—Metabolism—FASN—melanoma	1.64e-05	0.000204	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAP2K2—melanoma	1.63e-05	0.000204	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.63e-05	0.000203	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.63e-05	0.000203	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SLC5A5—melanoma	1.62e-05	0.000202	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.62e-05	0.000202	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SLC5A5—melanoma	1.61e-05	0.000201	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.57e-05	0.000196	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GNAQ—melanoma	1.56e-05	0.000195	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CD44—melanoma	1.56e-05	0.000195	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GNAQ—melanoma	1.56e-05	0.000194	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CD44—melanoma	1.56e-05	0.000194	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TERT—melanoma	1.55e-05	0.000194	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HLA-A—melanoma	1.55e-05	0.000194	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RAC1—melanoma	1.55e-05	0.000193	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL2—melanoma	1.54e-05	0.000192	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.53e-05	0.000191	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.52e-05	0.00019	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ABCB1—melanoma	1.52e-05	0.00019	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.52e-05	0.00019	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.51e-05	0.000188	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP1B1—melanoma	1.5e-05	0.000187	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP1B1—melanoma	1.49e-05	0.000186	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HIF1A—melanoma	1.48e-05	0.000185	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP17A1—melanoma	1.45e-05	0.000181	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.45e-05	0.000181	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.43e-05	0.000179	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.41e-05	0.000176	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PRKCA—melanoma	1.4e-05	0.000174	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ERCC2—melanoma	1.39e-05	0.000173	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CG—melanoma	1.38e-05	0.000172	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GNA11—melanoma	1.37e-05	0.000171	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NOS2—melanoma	1.35e-05	0.000168	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—FASN—melanoma	1.34e-05	0.000167	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NOTCH1—melanoma	1.34e-05	0.000167	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PPARG—melanoma	1.33e-05	0.000166	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.32e-05	0.000165	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SLC5A5—melanoma	1.32e-05	0.000165	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.32e-05	0.000164	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD80—melanoma	1.31e-05	0.000163	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KIT—melanoma	1.31e-05	0.000163	CbGpPWpGaD
Piroxicam—PTGS2—Disease—APC—melanoma	1.31e-05	0.000163	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VEGFA—melanoma	1.31e-05	0.000163	CbGpPWpGaD
Piroxicam—PTGS2—Disease—EGF—melanoma	1.29e-05	0.000161	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—NRAS—melanoma	1.29e-05	0.000161	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CD44—melanoma	1.27e-05	0.000159	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GNAQ—melanoma	1.27e-05	0.000159	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.25e-05	0.000156	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.24e-05	0.000154	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MAPK3—melanoma	1.24e-05	0.000154	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ABCB1—melanoma	1.24e-05	0.000154	CbGpPWpGaD
Piroxicam—PTGS2—Disease—BRAF—melanoma	1.23e-05	0.000153	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ABCB1—melanoma	1.23e-05	0.000153	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP1B1—melanoma	1.22e-05	0.000152	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CD—melanoma	1.21e-05	0.000151	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALB—melanoma	1.2e-05	0.000149	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MAPK1—melanoma	1.18e-05	0.000147	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAP2K1—melanoma	1.16e-05	0.000144	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CD—melanoma	1.15e-05	0.000143	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.15e-05	0.000143	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PRKCA—melanoma	1.14e-05	0.000142	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PRKCA—melanoma	1.13e-05	0.000141	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ERCC2—melanoma	1.13e-05	0.000141	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ERCC2—melanoma	1.12e-05	0.00014	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—KRAS—melanoma	1.11e-05	0.000139	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FGF2—melanoma	1.1e-05	0.000137	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CG—melanoma	1.09e-05	0.000137	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.08e-05	0.000135	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CB—melanoma	1.06e-05	0.000132	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PPARG—melanoma	1.06e-05	0.000132	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PTGS2—melanoma	1.05e-05	0.000131	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MDM2—melanoma	1.03e-05	0.000128	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CA—melanoma	1.02e-05	0.000127	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ERBB2—melanoma	1.01e-05	0.000127	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ABCB1—melanoma	1.01e-05	0.000126	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CB—melanoma	1e-05	0.000125	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD4—melanoma	1e-05	0.000125	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TP53—melanoma	9.87e-06	0.000123	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CD—melanoma	9.62e-06	0.00012	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALB—melanoma	9.5e-06	0.000119	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—HRAS—melanoma	9.44e-06	0.000118	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN1B—melanoma	9.4e-06	0.000117	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.34e-06	0.000117	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.29e-06	0.000116	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PRKCA—melanoma	9.25e-06	0.000116	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ERCC2—melanoma	9.18e-06	0.000115	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PTEN—melanoma	9.13e-06	0.000114	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CG—melanoma	8.91e-06	0.000111	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CTNNB1—melanoma	8.88e-06	0.000111	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CG—melanoma	8.86e-06	0.000111	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN1A—melanoma	8.67e-06	0.000108	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PTEN—melanoma	8.65e-06	0.000108	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PPARG—melanoma	8.6e-06	0.000107	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PPARG—melanoma	8.55e-06	0.000107	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CB—melanoma	8.39e-06	0.000105	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—AKT1—melanoma	8.33e-06	0.000104	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CD—melanoma	7.83e-06	9.77e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CD—melanoma	7.78e-06	9.72e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT3—melanoma	7.74e-06	9.66e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALB—melanoma	7.73e-06	9.65e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NRAS—melanoma	7.72e-06	9.64e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.6e-06	9.49e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAPK3—melanoma	7.39e-06	9.23e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CG—melanoma	7.25e-06	9.05e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PTEN—melanoma	7.25e-06	9.05e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MYC—melanoma	7.19e-06	8.98e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAPK1—melanoma	7.04e-06	8.78e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—EGFR—melanoma	7.03e-06	8.78e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PPARG—melanoma	7e-06	8.73e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CB—melanoma	6.82e-06	8.52e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CB—melanoma	6.79e-06	8.47e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PTGS2—melanoma	6.76e-06	8.44e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PTGS2—melanoma	6.72e-06	8.39e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KRAS—melanoma	6.65e-06	8.3e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CA—melanoma	6.44e-06	8.04e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CD—melanoma	6.37e-06	7.95e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALB—melanoma	6.29e-06	7.85e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CA—melanoma	6.11e-06	7.62e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PTEN—melanoma	5.9e-06	7.36e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PTEN—melanoma	5.86e-06	7.32e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HRAS—melanoma	5.65e-06	7.05e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CB—melanoma	5.55e-06	6.93e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PTGS2—melanoma	5.5e-06	6.87e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6—melanoma	5.41e-06	6.75e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—AKT1—melanoma	5.26e-06	6.57e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CA—melanoma	5.11e-06	6.38e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—AKT1—melanoma	4.99e-06	6.23e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PTEN—melanoma	4.8e-06	5.99e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—AKT1—melanoma	4.18e-06	5.21e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CA—melanoma	4.16e-06	5.19e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CA—melanoma	4.14e-06	5.16e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—AKT1—melanoma	3.4e-06	4.24e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CA—melanoma	3.39e-06	4.23e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—AKT1—melanoma	3.38e-06	4.22e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—AKT1—melanoma	2.77e-06	3.45e-05	CbGpPWpGaD
